Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page
- Check2 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new revision of the page. This update is a maintenance/version control change and does not alter the study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry, Revision: v3.5.4, was added to the page's revision history, indicating an update to the content. The previous Revision: v3.5.3 entry is superseded.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision history updated to include v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check95 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No content changes to the study details or page functionality are evident.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.